Skip to main content
. 2017 Aug 29;6(4):297–306. doi: 10.1159/000477134

Table 1.

Definitions of key clinical parameters used in the study

Complete remission Clinical status that is free of any residual primary liver tumor, intrahepatic recurrence, and extrahepatic nonpulmonary metastasis right before pulmonary metastasectomy

Partial response Clinical status not meeting the criteria of complete remission and showing a stable or reduced tumor size in the liver

Distant metastasis-free interval Interval between the date of the last treatment of HCC in the liver and the date of the first occurrence of lung metastasis; no metastatic disease elsewhere concurrently

Disease-free interval Interval between the date of curative surgery of intrahepatic lesion and the date of the first occurrence of lung metastasis

Overall survival Time from the initial pulmonary metastasectomy to the last follow-up date or death